Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice

Atherosclerosis

Volumn 184, Issue 2, 2006, Pages 312-321

  Ayabe, Nobuhiko ^a   Babaev, Vladimir R ^a   Tang, YiWei ^a   Tanizawa, Takakuni ^a   Fogo, Agnes B ^a   Linton, MacRae F ^a,b   Ichikawa, Iekuni ^a   Fazio, Sergio ^a   Kon, Valentina ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aneurysm; Angiotensin II; Atherosclerosis

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE;

ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; HYPERLIPIDEMIAS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; RNA;

EID: 30044437012     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.05.016     Document Type: Article

References (33)

1. V.J. Dzau Theodore cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis Hypertension 37 2001 1047 1052
2. E.J. Lewis, L.G. Hunsicker, and W.R. Clarke Collaborative Study Group: renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
3. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients New Engl J Med 342 2000 145 153
4. A. Daugherty, and L. Cassis Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice Ann N Y Acad Sci 892 1999 108 118
5. S. Keidar, R. Heinrich, M. Kaplan, T. Hayek, and M. Aviram Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized LDL: a possible role for interleukin-6 Arterioscler Thromb Vasc Biol 21 2001 1464 1469
6. D. Weiss, J.J. Kools, and W.R. Taylor Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice Circulation 103 2001 448 454
7. F. Sugiyama, S. Haraoka, and T. Watanabe Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system Lab Invest 76 1997 835 842
8. A. Daugherty, M.W. Manning, and L.A. Cassis Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice J Clin Invest 105 2000 1605 1612
9. R. Candido, K.A. Jandeleit-Dahm, and Z. Cao Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice Circulation 106 2002 246 253
10. F. Dol, G. Martin, and B. Staels Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apoprotein E-deficient mice J Cardiovasc Pharmacol 38 2001 395 405
11. D. Lombardi, K.L. Gordon, and P. Polinsky Salt-sensitive hypertension develops after short-term exposure to angiotensin II Hypertension 33 1999 1013 1019
12. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002;288:2981-97.
13. G.D. Laverman, G. Navis, R.H. Hennong, P.E. de Jong, and D. de Zeeuw Dual renin-angiotensin system blockade at optimal doses for proteinuria Kidney Int. 62 2002 1020 1025
14. S. Fazio, V.R. Babaev, and A.B. Murray Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages Proc Natl Acad Sci USA 94 1997 4647 4652
15. P.J. Kuhlencordt, R. Gyurko, and F. Han Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 2001 448 454
16. L. Gu, Y. Okada, and S.K. Clinton Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Mol Cell 2 1998 275 281
17. L. Boring, J. Gosling, M. Cleary, and I.F. Charo Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897
18. K.L. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real time quantitative PCR and the 2-Ct method Methods 25 2001 402 440
19. X. Deng, H. Li, and Y.W. Tang Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR J Virol Methods 107 2003 141 146
20. A. Daugherty, M.W. Manning, and L.A. Cassis Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis Br J Pharmacol 134 2001 865 870
21. K. Saraff, F. Babamusta, L.A. Casis, and A. Daugherty Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 23 2003 1623 1626
22. S. Keidar, M. Kaplan, and M. Aviram Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation Arterioscler Thromb Vasc Biol 16 1996 97 105
23. D. Steinberg Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime Nat Med 8 2002 1211 1217
24. X.L. Chen, P.E. Tummala, M.T. Olbrych, R.W. Alexander, and R.M. Medford Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells Circ Res 83 1998 952 959
25. N. van Royen, I. Hoefer, and M. Bottinger Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression Circ Res 92 2003 218 225
26. N. Ayabe, E. Suganuma, and V.R. Babaev Angiotensin II amplifies macrophage-driven atherosclerosis Arterioscler Thromb Vasc Biol 24 2004 1 6
27. K. Saraff, F. Babamusta, L.A. Cassis, and A. Daugherty Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 23 2003 1621 1626
28. R.L. Reddick, S.H. Zhang, and N. Maeda Atherosclerosis in mice lacking apoE. Evaluation of lesional development and progression Arterioscler Thromb 14 1994 141 147
29. M.W. Manning, L.A. Cassi, J. Huang, S.J. Szilvassy, and A. Daugherty Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease Vasc Med 7 2002 45 54
30. M.D. Tilson Aortic aneurysms and atherosclerosis Circulation 85 1992 378 379
31. T.A. Henriques, J. Huang, S.S. D'Souza, A. Daugherty, and L.A. Cassis Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice Endocrinology 145 2004 3866 3872
32. N. Nishijo, F. Sugiyama, and K. Kimoto Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II Lab Invest 78 1998 1059 1066
33. W. Huang, F. Alhenc Gelas, and M.J. Osborne-Pellegrin Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat Circ Res 82 1998 879 890